Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Genmab Research Grant Advancing Innovation in Ovarian and Endometrial Cancer

    Genmab Research Grant Advancing Innovation in Ovarian and Endometrial Cancer supports researchers studying folate receptor alpha expression during cancer progression to guide treatment and patient stratification.

    Browse similar grants
    Cancer Research Grants 2026New Research Grants This Month
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Foundation for Women's Cancer

    Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Invited full proposal)

    Funding Amounts: $50,000 for one year

    Summary: Supports research on folate receptor alpha expression across ovarian or endometrial cancer progression to improve treatment decisions and patient stratification.

    Key Information: Research must take place in the United States; non-SGO applicants need an SGO-member co-investigator or sponsor.


    Description

    The Genmab research grant, offered through the Foundation for Women's Cancer (FWC), supports studies of folate receptor alpha (FRα) expression throughout the disease trajectory of ovarian or endometrial cancer. It is part of FWC’s 2026–2027 Research Grants program, under Multi-Type Gynecologic Cancer Grants. Its central priority is to deepen understanding of how FRα expression changes during disease progression, informing treatment decisions, enabling more precise patient stratification, and ultimately improving clinical outcomes.

    Representation of underserved populations is highly valued in review. The grant also highlights unmet needs in rare ovarian and endometrial cancer histologies, including real-world testing, monitoring, disproportionate health outcomes in certain demographic groups, and quality of life.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.